Publication:
Clinical outcomes among ErbB2+MBC patients treated with lapatinib-capecitabine after trastuzumab progression: Role of early switch to lapatinib (TYCO study).

Thumbnail Image

Date

2012

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

AMER ASSOC CANCER RESEARCH

Research Projects

Organizational Units

Journal Issue

Abstract

Description

Keywords

Citation

URI

https://hdl.handle.net/11424/221465

Collections

Araştırma Çıktıları

Endorsement

Review

Supplemented By

Referenced By